SLXN Silexion Therapeutics: Bathi saben saham sajrone 12 wulan pungkasan

Silexion (SLXN) - logo korporat

The prospects of Silexion Therapeutics Corp (SLXN) depend on the outcomes of RNA drug trials, which necessitates strict capital management. The company plans to generate revenue from pancreatic cancer therapy via siRNA technologies. The YoY change in EPS on a rolling 12-month basis helps determine the real value of assets, where the current figure is 37.10. The success of a single molecule would ensure global reach and colossal profits with minimal expenditures.

Bathi saben saham sajrone rolas wulan pungkasan Silexion (SLXN): kanggo periode 23.11.2025 - 18.11.2026

SLXN (Silexion): rincian analitis lan laporan miturut indikator

- data kapitalisasi saham perusahaan:
Pambiji fundamental perusahaan:SLXN Silexion Therapeutics Corp
Barang unggulan Silexion Therapeutics Corp.

This indicator measures the dynamics of net earnings per share over a rolling year, reflecting the market's revaluation of business profitability. By analyzing the 12-month YoY earnings per share growth rate, an investor assesses the efficiency of corporate income capitalization. For Silexion Therapeutics Corp (SLXN), this metric is critical, as oncology RNA therapy is currently in the clinical testing stage. The future sustainability of the company depends directly on the commercialization of its platforms. High volatility on the chart underscores the risks associated with early-stage development.

Pesaing langsung

Bathi resik saben siji saham sajrone rolas wulan pungkasan Incyte Corp|HCM: Bathi resik saben saham (EPS TTM)|Bathi saben saham sajrone 12 wulan pungkasan NUVB|DAWN (dayonebio.com) - Bathi resik saben saham (EPS TTM)|Bathi resik saben saham sajrone 12 wulan pungkasan monopartx.com (MNPR)|Bathi saben saham sajrone rolas wulan pungkasan Inhibrx Corp (INBX)|IMAB - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Bathi saben saham sajrone rolas wulan pungkasan Fennec Pharmaceuticals Inc FENC|Heron Therapeutics - Bathi saben saham sajrone rolas wulan pungkasan|NVCT - Bathi saben saham sajrone rolas wulan pungkasan|Bathi resik saben siji saham sajrone rolas wulan pungkasan coherus.com|CRBP: Bathi resik saben saham (EPS TTM)|Bathi resik saben saham sajroning taun lumaku Cardiff Oncology, Inc. CRDF|Bathi resik saben saham sajrone 12 wulan pungkasan BYSI|Bathi resik saben siji saham sajrone rolas wulan pungkasan BioAtla BCAB|Bathi resik saben saham sajrone 12 wulan pungkasan LIXT (Lixte Biotechnology)|CTXR (Citius Pharma) - Bathi saben saham sajroning taun lumaku|Cellectar Biosciences - Bathi resik saben saham sajrone 12 wulan pungkasan|Bathi saben saham sajrone patang kuartal pungkasan BLRX (BioLineRx)|Can-Fite BioPharma, Ltd. - Bathi resik saben saham (EPS TTM)|Bathi saben saham sajroning taun lumaku APRE (aprea.com)|KZIA: Bathi resik saben saham (EPS TTM)|Bathi resik saben siji saham sajrone rolas wulan pungkasan NuCana Corp (NCNA)|Bathi saben saham sajrone rolas wulan pungkasan Chimerix|CYCC: Bathi saben saham sajroning taun lumaku|Bathi resik saben saham (EPS TTM) GTHX|Bathi resik saben saham (EPS TTM) Kronos Bio Corporation (KRON)|Bathi saben saham sajrone rolas wulan pungkasan Kintara KTRA|ONCT (Oncternal Therapeutics, Inc.) - Bathi saben siji saham sajrone 12 wulan pungkasan|PRTG: Bathi resik saben saham sajrone 12 wulan pungkasan